Follow
Cristina Joćo
Cristina Joćo
Hematologist and Researcher, Fundaēćo Champalimaud
Verified email at research.fchampalimaud.org - Homepage
Title
Cited by
Cited by
Year
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
M Dreyling, W Jurczak, M Jerkeman, RS Silva, C Rusconi, M Trneny, ...
The Lancet 387 (10020), 770-778, 2016
5072016
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
J Hillengass, S Usmani, SV Rajkumar, BGM Durie, MV Mateos, S Lonial, ...
The lancet oncology 20 (6), e302-e312, 2019
3682019
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label …
PG Richardson, A Oriol, M Beksac, AM Liberati, M Galli, F Schjesvold, ...
The Lancet Oncology 20 (6), 781-794, 2019
3472019
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
P Moreau, SK Kumar, J San Miguel, F Davies, E Zamagni, N Bahlis, ...
The Lancet Oncology 22 (3), e105-e118, 2021
1862021
The production processes and biological effects of intravenous immunoglobulin
AF Barahona Afonso, CMP Joćo
Biomolecules 6 (1), 15, 2016
1092016
B cell-dependent TCR diversification
C João, BM Ogle, C Gay-Rabinstein, JL Platt, M Cascalho
The Journal of Immunology 172 (8), 4709-4716, 2004
1032004
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, F Offner, ...
Leukemia 32 (8), 1799-1803, 2018
912018
Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma
C Joao, LF Porrata, DJ Inwards, SM Ansell, IN Micallef, PB Johnston, ...
Bone Marrow Transplantation 37 (9), 865-871, 2006
892006
Direct measurement of lymphocyte receptor diversity
BM Ogle, M Cascalho, C Joao, W Taylor, LJ West, JL Platt
Nucleic acids research 31 (22), e139-e139, 2003
392003
The immune microenvironment in multiple myeloma: friend or foe?
R Lopes, J Caetano, B Ferreira, F Barahona, EA Carneiro, C Joao
Cancers 13 (4), 625, 2021
362021
Passive serum therapy to immunomodulation by IVIG: a fascinating journey of antibodies
C Joćo, VS Negi, MD Kazatchkine, J Bayry, SV Kaveri
The Journal of Immunology 200 (6), 1957-1963, 2018
332018
Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells
N Costa, AE Pires, AM Gabriel, LF Goulart, C Pereira, B Leal, AC Queiros, ...
Journal of clinical immunology 33, 349-360, 2013
272013
Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence in situ hybridization (FISH) study
C Joao, P Farinha, MG Da Silva, C Martins, M Crespo, J Cabecadas
Histopathology 50 (2), 217-224, 2007
272007
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low‐dose dexamethasone: A pooled analysis
P Moreau, MA Dimopoulos, PG Richardson, DS Siegel, M Cavo, ...
European journal of haematology 99 (3), 199-206, 2017
262017
Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution
C Joćo
Medical hypotheses 68 (1), 158-161, 2007
262007
Immunoglobulin promotes the diversity and the function of T cells
C Joćo, BM Ogle, S Geyer
European journal of immunology 36 (7), 1718-1728, 2006
262006
Liquid biopsies for multiple myeloma in a time of precision medicine
B Ferreira, J Caetano, F Barahona, R Lopes, E Carneiro, B Costa-Silva, ...
Journal of Molecular Medicine 98, 513-525, 2020
252020
Long‐term survival in multiple myeloma
C Joao, C Costa, I Coelho, MJ Vergueiro, M Ferreira, MG da Silva
Clinical case reports 2 (5), 173-179, 2014
232014
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated …
G Hess, S Rule, W Jurczak, M Jerkeman, R Santucci Silva, C Rusconi, ...
Leukemia & Lymphoma 58 (12), 2824-2832, 2017
182017
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018
G Palladini, S Schönland, G Merlini, P Milani, A Jaccard, F Bridoux, ...
Blood cancer journal 13 (1), 19, 2023
162023
The system can't perform the operation now. Try again later.
Articles 1–20